Acelyrin Vs. Arbutus Biopharma Industry Stock Comparison

Sell

20

SLRN
Acelyrin

Last Price:

3.23

Seasonality Move:

21.52%

Sell

29

ABUS
Arbutus Biopharma

Last Price:

3.49

Seasonality Move:

25.39%

Sell

20

Acelyrin (SLRN) is a Sell

Is Acelyrin a Buy, Sell or Hold?

The current Acelyrin [SLRN] share price is $3.23. The Score for SLRN is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
SLRN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

29

Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

The current Arbutus Biopharma [ABUS] share price is $3.48. The Score for ABUS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
ABUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SLRN Stock Price Chart

What is Acelyrin's stock price today?

The Acelyrin share price today is $3.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLRN is experiencing slight selling pressure.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

The Arbutus Biopharma share price today is $3.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight selling pressure.

SLRN Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.47	Sell
Relative Strength Index (14 RSI):	23.33	Sell
Chaikin Money Flow:	-382140	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.87 - 5.33)	Sell
Bollinger Bands (100):	(4.32 - 5.84)	Sell

ABUS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.04	Sell
Relative Strength Index (14 RSI):	41.86	Sell
Chaikin Money Flow:	-242033	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(3.45 - 3.69)	Sell
Bollinger Bands (100):	(3.59 - 4.11)	Sell

SLRN Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	3.9	Sell
20-day SMA:	4.3	Sell
50-day SMA:	5.18	Sell
200-day SMA:	5.28	Sell
8-day EMA:	3.81	Sell
20-day EMA:	4.31	Sell
50-day EMA:	4.82	Sell
200-day EMA:	6.34	Sell

ABUS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	3.65	Sell
20-day SMA:	3.54	Sell
50-day SMA:	3.75	Sell
200-day SMA:	3.43	Buy
8-day EMA:	3.59	Sell
20-day EMA:	3.61	Sell
50-day EMA:	3.7	Sell
200-day EMA:	3.45	Buy

Acelyrin Earnings Growth & SLRN Earnings Dates

Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.95 per share, and an increase next year of $0.40 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Acelyrin Technical Analysis

	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13
	Dec
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13
	Dec
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):